Robert Coffin, President & Chief R&D Officer at Replimune Group, Inc. (REPL), sold 169,750 shares at $22.32 ($3.8M) on 2020-07-09, disclosed to the SEC on 2020-07-10.
Open-market sale of $3.8M REPL by President & Chief R&D Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.02 | 24,250 | $510K | 13.6% |
| 2 | $22.32 | 145,500 | $3.2M | 86.4% |
| Total | $22.13 avg | 169,750 | $3.8M | 100% |
| Filing → |
| REPL | SELL | 2022-05-18 | $167K | — | Filing → |
| REPL | SELL | 2021-07-07 | $625K | — | Filing → |
| REPL | SELL | 2021-06-30 | $3.0M | — | Filing → |